Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Performer
2805.7000 36.60 (1.32%)
NSE May 02, 2025 10:44 AM
Volume: 55,439
 

2805.70
1.32%
Ashika Research
The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the sale of 11,600,000 Equity Shares by the Selling Shareholders. The Company will not receive any proceeds of...
Emkay increased Buy price target of Dr. Lal Pathlabs Ltd. to 3100.0 on 26 Apr, 2025.
More from Dr. Lal Pathlabs Ltd.
Recommended